NASDAQ: QIPTQuipt Home Medical Corp Stock
$2.15-0.02 (-0.92%)
Updated Apr 30, 2025
QIPT Price
$2.15
Fair Value Price
N/A
Market Cap
$92.65M
52 Week Low
$1.86
52 Week High
$4.17
P/E
-12.65x
P/B
0.87x
P/S
0.54x
PEG
N/A
Dividend Yield
N/A
Revenue
$241.93M
Earnings
-$7.26M
Gross Margin
20.7%
Operating Margin
-0.15%
Profit Margin
-3%
Debt to Equity
1.28
Operating Cash Flow
$33M
Beta
0.6
Next Earnings
May 13, 2025
Ex-Dividend
N/A
Next Dividend
N/A
QIPT Overview
Quipt Home Medical Corp. offers in-home medical equipment and supplies, and respiratory and durable medical equipment in the U.S. Offerings include nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment and aids, daily and ambulatory aides, equipment solutions, power wheelchairs, oxygen therapy, and related equipment. Quipt Home Medical was incorporated in 1993 and is headquartered in Wilder, KY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine QIPT's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
QIPT
Ranked#48 of 108
Ranked#48 of 108
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $7.31 | A | |
| $23.03 | A | |
| $14.12 | A |
Be the first to know about important QIPT news, forecast changes, insider trades & much more!
QIPT News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how QIPT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
QIPT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
QIPT is good value based on its book value relative to its share price (0.87x), compared to the US Medical Devices industry average (3.94x)
P/B vs Industry Valuation
QIPT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more QIPT due diligence checks available for Premium users.
Valuation
QIPT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-12.65x
Industry
37.39x
Market
29.18x
QIPT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.87x
Industry
3.94x
QIPT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
QIPT's financial health
Profit margin
Revenue
$61.4M
Net Income
-$1.1M
Profit Margin
-1.8%
QIPT's Earnings (EBIT) of -$367.00k... subscribe to Premium to read more.
Interest Coverage Financials
QIPT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$242.8M
Liabilities
$136.5M
Debt to equity
1.28
QIPT's short-term assets ($69.66M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
QIPT's long-term liabilities ($79.42M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
QIPT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$9.3M
Investing
-$3.6M
Financing
-$5.5M
QIPT's operating cash flow ($32.95M)... subscribe to Premium to read more.
Debt Coverage Financials
QIPT vs Medical Device Stocks
Quipt Home Medical Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.